Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MG4101 in Hepatocellular Carcinoma After Curative Resection
NCT02008929Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Aug 2014
- Primary completion
- Oct 2015
- Countries
- 1
01
Overview
A Phase 2 trial of MG4101 in hepatocellular carcinoma (HCC), sponsored by Samsung Medical Center. Started Aug 2014; status: completed.
02
Drugs
MG4101
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02008929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008929.